BP PLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2017. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
BP PLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2019$1,130,000
-7.8%
28,137
+51.1%
0.04%0.0%
Q4 2017$1,226,00018,6240.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2017
NameSharesValueWeighting ↓
Meditor Group Ltd 2,629,835$116,685,00025.08%
Aviva Holdings Ltd. 1,200,100$53,248,00014.21%
Boxer Capital, LLC 1,375,000$61,009,0006.77%
BB BIOTECH AG 3,282,964$145,665,0003.86%
Rhenman & Partners Asset Management AB 353,961$15,705,0001.57%
PFM Health Sciences, LP 1,970,134$87,415,0001.28%
Bellevue Group AG 391,852$17,386,0001.10%
Pentwater Capital Management LP 2,351,500$104,336,0000.88%
Partner Investment Management, L.P. 25,440$1,129,0000.86%
SABBY MANAGEMENT, LLC 100,369$4,453,0000.57%
View complete list of ESPERION THERAPEUTICS INC NE shareholders